Moneycontrol
    Moneycontrol PRO
    LAMF
    LAMF

    Jump to

    • Here's what Cadila has to say about US price erosion concerns

    • TCS biggest wealth creator in 2012-17, Ajanta Pharma the fastest: Wealth Creation Study

    • Want to significantly expand emerging market business: Cadila

    • Aim to develop and market molecules in India first: Zydus Cadila

    • Pricing pressure in US biz cyclical in nature: Cadila Health

    • Indian pharma cos need to step-up safeguards at plants: Handa

    • No data integrity issue at Moraiya facility: Cadila Health

    • Indian pharma to revive by Apr; see better margins: Cadila

    • Zydus Cadila to launch Lipaglyn in other mkts in 3-5 yrs

      Cadila's CMD Pankaj Patel says global market size for Lipaglyn type of drug is around USD 29 billion. The drug is expected to be launched in India in Q3 and in other markets in 3-5 years.

    Advisory Alert:

    It has come to our attention that certain individuals are representing themselves as affiliates of Moneycontrol and soliciting funds on the false promise of assured returns on their investments. We wish to reiterate that Moneycontrol does not solicit funds from investors and neither does it promise any assured returns. In case you are approached by anyone making such claims, please write to us at grievanceofficer@nw18.com or call on 02268882347